Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Eloxx Pharmaceuticals, Inc. | PRESIDENT AND CEO, Director | Restricted Stock Units | 60K | $43.2K | $0.72 | Jan 24, 2024 | Direct |
Eloxx Pharmaceuticals, Inc. | PRESIDENT AND CEO, Director | Common Stock | 170K | Oct 16, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ELOX | Eloxx Pharmaceuticals, Inc. | Oct 16, 2024 | 1 | $0 | 4 | Oct 17, 2024 | PRESIDENT AND CEO, Director |
ELOX | Eloxx Pharmaceuticals, Inc. | Jan 24, 2024 | 1 | $0 | 4 | Jan 26, 2024 | PRESIDENT AND CEO, Director |
ELOX | Eloxx Pharmaceuticals, Inc. | Jan 25, 2023 | 1 | $0 | 4 | Jan 27, 2023 | PRESIDENT AND CEO, Director |
ELOX | Eloxx Pharmaceuticals, Inc. | Dec 1, 2021 | 3 | -$59K | 4 | Dec 3, 2021 | PRESIDENT AND CEO, Director |
ELOX | Eloxx Pharmaceuticals, Inc. | May 18, 2021 | 1 | $0 | 4 | May 18, 2021 | PRESIDENT AND CEO, Director |